227 related articles for article (PubMed ID: 20824628)
1. Brain expression of Cre recombinase driven by pancreas-specific promoters.
Song J; Xu Y; Hu X; Choi B; Tong Q
Genesis; 2010 Nov; 48(11):628-34. PubMed ID: 20824628
[TBL] [Abstract][Full Text] [Related]
2. Development of a transgenic mouse model using rat insulin promoter to drive the expression of CRE recombinase in a tissue-specific manner.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Int J Pancreatol; 1999 Jun; 25(3):157-63. PubMed ID: 10453417
[TBL] [Abstract][Full Text] [Related]
3. Precise pattern of recombination in serotonergic and hypothalamic neurons in a Pdx1-cre transgenic mouse line.
Honig G; Liou A; Berger M; German MS; Tecott LH
J Biomed Sci; 2010 Oct; 17(1):82. PubMed ID: 20950489
[TBL] [Abstract][Full Text] [Related]
4. Cre-mediated transgene activation in the developing and adult mouse brain.
Cinato E; Mirotsou M; Sablitzky F
Genesis; 2001 Nov; 31(3):118-25. PubMed ID: 11747202
[TBL] [Abstract][Full Text] [Related]
5. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
Licht AH; Raab S; Hofmann U; Breier G
Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
[TBL] [Abstract][Full Text] [Related]
7. Neuron-specific expression of Cre recombinase during the late phase of brain development.
Hirasawa M; Cho A; Sreenath T; Sauer B; Julien JP; Kulkarni AB
Neurosci Res; 2001 Jun; 40(2):125-32. PubMed ID: 11377750
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
[TBL] [Abstract][Full Text] [Related]
9. Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain.
Wicksteed B; Brissova M; Yan W; Opland DM; Plank JL; Reinert RB; Dickson LM; Tamarina NA; Philipson LH; Shostak A; Bernal-Mizrachi E; Elghazi L; Roe MW; Labosky PA; Myers MG; Gannon M; Powers AC; Dempsey PJ
Diabetes; 2010 Dec; 59(12):3090-8. PubMed ID: 20802254
[TBL] [Abstract][Full Text] [Related]
10. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.
Zhuo L; Theis M; Alvarez-Maya I; Brenner M; Willecke K; Messing A
Genesis; 2001 Oct; 31(2):85-94. PubMed ID: 11668683
[TBL] [Abstract][Full Text] [Related]
11. Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes.
Dietrich P; Dragatsis I; Xuan S; Zeitlin S; Efstratiadis A
Mamm Genome; 2000 Mar; 11(3):196-205. PubMed ID: 10723724
[TBL] [Abstract][Full Text] [Related]
12. Conditional gene deletion in primary nociceptive neurons of trigeminal ganglia and dorsal root ganglia.
Agarwal N; Offermanns S; Kuner R
Genesis; 2004 Mar; 38(3):122-9. PubMed ID: 15048809
[TBL] [Abstract][Full Text] [Related]
13. Differential oocyte-specific expression of Cre recombinase activity in GDF-9-iCre, Zp3cre, and Msx2Cre transgenic mice.
Lan ZJ; Xu X; Cooney AJ
Biol Reprod; 2004 Nov; 71(5):1469-74. PubMed ID: 15215191
[TBL] [Abstract][Full Text] [Related]
14. A transgenic mouse that targets the expression of Cre recombinase in pancreatic tissue.
Zhou J; Cheng X; Lu YX; Huang CF; Yang X
Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):286-90. PubMed ID: 12192858
[TBL] [Abstract][Full Text] [Related]
15. Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain.
Sinnayah P; Lindley TE; Staber PD; Davidson BL; Cassell MD; Davisson RL
Physiol Genomics; 2004 Jun; 18(1):25-32. PubMed ID: 15069166
[TBL] [Abstract][Full Text] [Related]
16. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
17. Inducible cardiomyocyte-specific gene disruption directed by the rat Tnnt2 promoter in the mouse.
Wu B; Zhou B; Wang Y; Cheng HL; Hang CT; Pu WT; Chang CP; Zhou B
Genesis; 2010 Jan; 48(1):63-72. PubMed ID: 20014345
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
Jin C; McKeehan K; Wang F
Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
[TBL] [Abstract][Full Text] [Related]
19. Reporter expression, induced by a growth hormone promoter-driven Cre recombinase (rGHp-Cre) transgene, questions the developmental relationship between somatotropes and lactotropes in the adult mouse pituitary gland.
Luque RM; Amargo G; Ishii S; Lobe C; Franks R; Kiyokawa H; Kineman RD
Endocrinology; 2007 May; 148(5):1946-53. PubMed ID: 17289844
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell-specific expression of Cre recombinase in transgenic mice.
Li WL; Cheng X; Tan XH; Zhang JS; Sun YS; Chen L; Yang X
Yi Chuan Xue Bao; 2005 Sep; 32(9):909-15. PubMed ID: 16201233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
